EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Polymyalgia Rheumatica

Christian Dejaco, Eric L Matteson

New England Journal of Medicine · 12.03.2026 · 394 (11) · 1097-1109

DOI: 10.1056/nejmcp2506817 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift New England Journal of Medicine, erschienen am 12.03.2026. Verfasst von Christian Dejaco und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology, Medical University Graz, Graz, Austria. Hauptthemen laut MEDLINE: Glucocorticoids, Polymyalgia Rheumatica, Myalgia. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 50 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Polymyalgia rheumatica is an inflammatory condition that affects persons older than 50 years of age and is characterized by pain in both shoulders with or without hip or neck pain (or both) and with pronounced morning stiffness. The condition is typically diagnosed on the basis of these hallmark symptoms along with elevated inflammation markers (erythrocyte sedimentation rate and C-reactive protein level) and the ruling out of other conditions including giant-cell arteritis. Glucocorticoids are the primary treatment, which provide rapid symptom relief. The initial dose, usually 12.5 to 25 mg of prednisone equivalent daily, is gradually reduced, ideally over 12 months or less, although the disease course varies and polymyalgia rheumatica may persist for a longer duration. Relapses are common and sometimes warrant the use of interleukin-6 receptor inhibitors or methotrexate to minimize glucocorticoid exposure.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlucocorticoidsPolymyalgia RheumaticaMyalgiaAgedHumansMiddle AgedBlood SedimentationC-Reactive ProteinDiagnosis, DifferentialGiant Cell ArteritisPrednisoneRecurrenceAged, 80 and overDose-Response Relationship, DrugMethotrexateReceptors, Interleukin-6Treatment OutcomeAntibodies, Monoclonal, HumanizedDrug Therapy, CombinationDrug TaperingArthritis, RheumatoidChondrocalcinosis

Substanzen

C-Reactive ProteinGlucocorticoidsPrednisoneMethotrexateReceptors, Interleukin-6Antibodies, Monoclonal, Humanized

Autor:innen und Institutionen

  • Department of Rheumatology, Medical University Graz, Graz, Austria.
  • Department of Rheumatology, Hospital of Brunico (Südtiroler Sanitätsbetrieb-Azienda Sanitaria dell'Alto Adige), Teaching Hospital of the Paracelsus Medical University, Brunico, Italy.
  • Division of Rheumatology, Mayo Clinic College of Medicine and Science, Rochester, MN.

Zitieren

APA

Dejaco, C., & Matteson, E. L. (2026). Polymyalgia Rheumatica. New England Journal of Medicine, 394(11), 1097-1109. https://doi.org/10.1056/nejmcp2506817

Vancouver

Dejaco C, Matteson EL. Polymyalgia Rheumatica. New England Journal of Medicine. 2026;394(11):1097-1109. doi:10.1056/nejmcp2506817

BibTeX
@article{Dejaco2026,
  author = {Dejaco, Christian and Matteson, Eric L},
  title = {Polymyalgia Rheumatica},
  journal = {New England Journal of Medicine},
  year = {2026},
  volume = {394},
  number = {11},
  pages = {1097--1109},
  doi = {10.1056/nejmcp2506817}
}
Kostenlos starten →